The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome-Reference-Cited by-同舟云学术

The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome

Published:2019-11 Issue:6 Volume:18 Page:829-837
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Heirali Alya A.,Acosta Nicole,Storey Douglas G.,Workentine Matthew L.,Somayaji Ranjani,Laforest-Lapointe Isabelle,Leung Winnie,Quon Bradley S.,Berthiaume Yves,Rabin Harvey R.,Waddell Barbara J.,Rossi Laura,Surette Michael G.,Parkins Michael D.^ORCID

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference50 articles.

1. The changing microbial epidemiology in cystic fibrosis;Lipuma;Clin Microbiol Rev,2010

2. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health;Mogayzel;Am J Respir Crit Care Med,2013

3. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group;Ramsey;N Engl J Med,1999

4. Microbiological and immunologic considerations with aerosolized drug delivery;LiPuma;Chest,2001

5. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis;McCoy;Am J Respir Crit Care Med,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract;Expert Opinion on Drug Delivery;2024-07-02

2. The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection;Frontiers in Microbiology;2024-04-16

3. Targeting respiratory microbiomes in COPD and bronchiectasis;Expert Review of Respiratory Medicine;2024-04-02

4. Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint;European Respiratory Journal;2024-02

5. Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders;Lung;2023-09-26